We are live on
!
Find out more
JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$45.3M
1-Year Est. Return
42.75%
This Fund
S&P 500
This Quarter
Est. Return
+10.57%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$97.4M
AUM Growth
+$22M
(+29%)
Cap. Flow
+$20.5M
Cap. Flow
% of AUM
21.05%
Top 10 Holdings %
Top 10 Hldgs %
87.15%
Holding
39
New
24
Increased
1
Reduced
2
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Galicia Financial Group
GGAL
|
+$13.1M |
| 2 |
Kraft Heinz
KHC
|
+$10.2M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$9.78M |
| 4 |
Mercado Libre
MELI
|
+$9.38M |
| 5 |
NGD
New Gold Inc
NGD
|
+$7.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.47M |
| 2 |
UnitedHealth
UNH
|
+$1.46M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.31M |
| 4 |
Eli Lilly
LLY
|
+$529K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$472K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.77% |
| 2 | Materials | 18.44% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Consumer Staples | 9.73% |
| 5 | Healthcare | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CALL
VanEck Gold Miners ETF
GDX
$25.5B
| $51K | 0.05% |
+2,200
| New | +$50.8K |
|
27
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.5B
| – | – |
-350,000
| Closed | -$14.5M |
|
|
28
CALL
iShares MSCI Brazil ETF
EWZ
$9.14B
| – | – |
-2,300
| Closed | -$79K |
|
|
29
Eli Lilly
LLY
$1.04T
| – | – |
-6,426
| Closed | -$529K |
|
30
Neurocrine Biosciences
NBIX
$16.4B
| – | – |
-5,890
| Closed | -$271K |
|
31
PUT
Invesco QQQ Trust
QQQ
$480B
| – | – |
-180,000
| Closed | -$24.8M |
|
|
32
Regeneron Pharmaceuticals
REGN
$79.1B
| – | – |
-961
| Closed | -$472K |
|
33
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| – | – |
-100,000
| Closed | -$24.2M |
|
|
34
UnitedHealth
UNH
$375B
| – | – |
-7,850
| Closed | -$1.46M |
|
35
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-2,697
| Closed | -$348K |
|
|
ALXN
36
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-10,743
| Closed | -$1.31M |
|
|
TSRO
37
DELISTED
TESARO, Inc.
TSRO
| – | – |
-2,294
| Closed | -$321K |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| – | – |
-11,333
| Closed | -$1.47M |
|
Similar funds
SM
PCM
CG
ICCON
CM
MCMC
CAS
RRC
JGP Global Gestao de Recursos's Q3 2017 Portfolio in Review
As of Q3 2017, JGP Global Gestao de Recursos held 39 positions worth $97.4M, up 29% from $75.4M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
JGP Global Gestao de Recursos deployed $20.5M of net new capital in Q3 2017, opening 24 new positions and adding to 1 existing holding. Its largest new stake was Galicia Financial Group: 307,314 shares worth $15.8M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Materials and Consumer Discretionary.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $67K trimmed.
- JGP Global Gestao de Recursos's largest Q3 2017 buy was Galicia Financial Group: 307,314 shares worth $15.8M.
- JGP Global Gestao de Recursos added most to Seagen Inc. Common Stock in Q3 2017, an estimated $49.6K increase.
- JGP Global Gestao de Recursos's biggest Q3 2017 reduction was BioMarin Pharmaceuticals, cutting an estimated $67K.
- JGP Global Gestao de Recursos fully exited Celgene Corp in Q3 2017, selling an estimated $1.47M.
- JGP Global Gestao de Recursos's ten largest holdings make up 87% of its $97.4M portfolio in Q3 2017.
- JGP Global Gestao de Recursos opened 24 new positions and closed 12 in Q3 2017.
- JGP Global Gestao de Recursos's portfolio value rose 29% quarter-over-quarter to $97.4M.
Based on JGP Global Gestao de Recursos's 13F filing for Q3 2017, filed 9 Nov 2017.